<DOC>
	<DOCNO>NCT02584686</DOCNO>
	<brief_summary>Evidence arise Botulinum toxin injection relax smooth muscle fiber treatment obesity hyperactive bladder . Would similar effect cavernosal smooth muscle help treatment resistant erectile dysfunction respond medical injection therapy , thus avoid surgical treatment option . The treatment group inject intracavernously 50 unit BTX-A . The control group , 12 patient , inject normal saline injection .</brief_summary>
	<brief_title>Intracavernosal Injection Botulinum Toxin Type A Treatment Vascular Erectile Dysfunction</brief_title>
	<detailed_description>24 male include study . All subject full history taking , general genital examination . Penile duplex perform assess vascular etiology treatment 2 week later . The patient randomize treatment group ( 12 patient ) control group ( 12 patient ) . All patient sign inform consent . The treatment group inject IC trimix solution ( 20 ug alprostadil + 1 mg phentolamine + 30 mg papaverine ) color Doppler assessment , follow , next day 50 unit BTX-A . The control group , 12 patient , injected trimix solution penile color Doppler assessment follow next day normal saline injection . The erection hardness score ( EHS ) assess Doppler exam . Procedure : At least 1 day penile color Doppler test , patient place supine position flaccid stretch penile length girth would measure tip penis pubic bone do . A rubber band apply base penis . The skin prepped alcohol swab follow IC injection 50 unit BTX-A . Direct pressure apply 2 minute . The rubber band remove 15 minute . Patients control fill Sexual Health Inventory men ( SHIM ) questionnaire answer Sexual Encounter Profile question 1 2 ( SEP 2 &amp; SEP 3 ) , global assessment question ( GAQ ) 4 week treatment . The rational selecting minimum 2-weeks wait period give chance BTX-A reach maximum effect . Possible Risks include pain prolonged erection .</detailed_description>
	<mesh_term>Erectile Dysfunction</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Botulinum Toxins , Type A</mesh_term>
	<mesh_term>incobotulinumtoxinA</mesh_term>
	<mesh_term>abobotulinumtoxinA</mesh_term>
	<mesh_term>onabotulinumtoxinA</mesh_term>
	<mesh_term>Botulinum Toxins</mesh_term>
	<criteria>24 male include study recruit Andrology , Sexology &amp; STD 's outpatient clinic , Kasr El Aini Hospitals , Cairo University , complain Vascular ED prove penile duplex . Unable develop erection sufficient intercourse . Failing respond first line second line treatment Erectile Dysfunction surgery remain treatment option . Age 40 70 year . Significant cardiovascular disease interfere sexual activity</criteria>
	<gender>Male</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>